217 related articles for article (PubMed ID: 16778751)
1. Metabolic syndrome in subjects with essential hypertension: relationships with subclinical cardiovascular and renal damage.
Mulé G; Cottone S; Nardi E; Andronico G; Cerasola G
Minerva Cardioangiol; 2006 Apr; 54(2):173-94. PubMed ID: 16778751
[TBL] [Abstract][Full Text] [Related]
2. Influence of metabolic syndrome on hypertension-related target organ damage.
Mulè G; Nardi E; Cottone S; Cusimano P; Volpe V; Piazza G; Mongiovì R; Mezzatesta G; Andronico G; Cerasola G
J Intern Med; 2005 Jun; 257(6):503-13. PubMed ID: 15910554
[TBL] [Abstract][Full Text] [Related]
3. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy.
Cordero A; Laclaustra M; León M; Grima A; Casasnovas JA; Luengo E; del Rio A; Ferreira I; Alegria E
Am J Hypertens; 2006 Feb; 19(2):189-96; discussion 197-8. PubMed ID: 16448891
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension.
Leoncini G; Ratto E; Viazzi F; Vaccaro V; Parodi A; Falqui V; Conti N; Tomolillo C; Deferrari G; Pontremoli R
J Hum Hypertens; 2007 Oct; 21(10):802-7. PubMed ID: 17541383
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of the metabolic syndrome, 2002.
Meigs JB
Am J Manag Care; 2002 Sep; 8(11 Suppl):S283-92; quiz S293-6. PubMed ID: 12240700
[TBL] [Abstract][Full Text] [Related]
6. Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients.
Mulè G; Cottone S; Mongiovì R; Cusimano P; Mezzatesta G; Seddio G; Volpe V; Nardi E; Andronico G; Piazza G; Cerasola G
Nutr Metab Cardiovasc Dis; 2006 Jan; 16(1):54-9. PubMed ID: 16399492
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
[TBL] [Abstract][Full Text] [Related]
9. The metabolic syndrome and cardiovascular disease.
Bonora E
Ann Med; 2006; 38(1):64-80. PubMed ID: 16448990
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
[TBL] [Abstract][Full Text] [Related]
11. Age and target organ damage in essential hypertension: role of the metabolic syndrome.
Cuspidi C; Meani S; Valerio C; Sala C; Fusi V; Zanchetti A; Mancia G
Am J Hypertens; 2007 Mar; 20(3):296-303. PubMed ID: 17324743
[TBL] [Abstract][Full Text] [Related]
12. The relationship between hyperinsulinemia, hypertension and progressive renal disease.
El-Atat FA; Stas SN; McFarlane SI; Sowers JR
J Am Soc Nephrol; 2004 Nov; 15(11):2816-27. PubMed ID: 15504934
[TBL] [Abstract][Full Text] [Related]
13. The implications of anthropometric, inflammatory and glycaemic control indices in the epidemiology of the metabolic syndrome given by different definitions: a classification analysis.
Panagiotakos DB; Pitsavos C; Das UN; Skoumas Y; Stefanadis C
Diabetes Obes Metab; 2007 Sep; 9(5):660-8. PubMed ID: 17697058
[TBL] [Abstract][Full Text] [Related]
14. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome.
Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study.
Navarro J; Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Bonet A; González-Esteban J
Blood Press; 2007; 16(1):20-7. PubMed ID: 17453748
[TBL] [Abstract][Full Text] [Related]
17. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
de Simone G; Olsen MH; Wachtell K; Hille DA; Dahlöf B; Ibsen H; Kjeldsen SE; Lyle PA; Devereux RB
J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population.
Strazzullo P; Barbato A; Siani A; Cappuccio FP; Versiero M; Schiattarella P; Russo O; Avallone S; della Valle E; Farinaro E
Metabolism; 2008 Mar; 57(3):355-61. PubMed ID: 18249207
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness.
Zanchetti A; Hennig M; Baurecht H; Tang R; Cuspidi C; Carugo S; Mancia G
J Hypertens; 2007 Dec; 25(12):2463-70. PubMed ID: 17984668
[TBL] [Abstract][Full Text] [Related]
20. Hypertension, insulin resistance, and the metabolic syndrome.
Natali A; Ferrannini E
Endocrinol Metab Clin North Am; 2004 Jun; 33(2):417-29. PubMed ID: 15158527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
